{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:17:40Z","timestamp":1790360260712,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.forsciint.2019.109914","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T11:34:38Z","timestamp":1564659278000},"page":"109914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Prevalence of therapeutic drugs in blood of drivers involved in traffic crashes in the area of Bologna, Italy"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3263-1758","authenticated-orcid":false,"given":"Guido","family":"Pelletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0956-3315","authenticated-orcid":false,"given":"Alain G.","family":"Verstraete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Reyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Garagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2214-8885","authenticated-orcid":false,"given":"Susi","family":"Pelotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.forsciint.2019.109914_bib0005","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-2125.2012.04279.x","article-title":"A European approach to categorizing medicines for fitness to drive: outcomes of the DRUID project","volume":"74","author":"Ravera","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2019.109914_bib0010","series-title":"Driving Under the Influence of Drugs, Alcoholand Medicines in Europe\u2014Findings From the DRUID Project","author":"Schulze","year":"2012"},{"key":"10.1016\/j.forsciint.2019.109914_bib0015","series-title":"Classification of medicinal drugs and driving: coordination and synthesis report, Deliverable 4.4.1 in the 6FP DRUID","author":"G\u00f3mez Taleg\u00f3n","year":"2011"},{"issue":"6","key":"10.1016\/j.forsciint.2019.109914_bib0020","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/alcalc\/agy050","article-title":"The dangerous pattern of concurrent use of alcohol and cocaine among drunk-drivers of Northeast Italy","volume":"53","author":"Snenghi","year":"2018","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.forsciint.2019.109914_bib0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugalcdep.2014.10.013","article-title":"Impairment due to amphetamines and benzodiazepines, alone and in combination","volume":"145","author":"Hoiseth","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.forsciint.2019.109914_bib0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/dta.1393","article-title":"Alcohol and drugs in seriously injured drivers in six European countries","volume":"5","author":"Legrand","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2019.109914_bib0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.forsciint.2018.05.003","article-title":"Alcohol and drugs use among drivers injured in road accidents in Campania (Italy): a 8-years retrospective analysis","volume":"288","author":"Carfora","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2019.109914_bib0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.forsciint.2018.04.038","article-title":"Toxicological investigation in blood samples from suspected impaired driving cases in the Milan area: possible loss of evidence due to late blood sampling","volume":"288","author":"Ferrari","year":"2018","journal-title":"Forensic Sci. Int."},{"issue":"8","key":"10.1016\/j.forsciint.2019.109914_bib0045","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1360-0443.2008.02277.x","article-title":"Guidelines for research on drugged driving","volume":"103","author":"Walsh","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2019.109914_bib0050","series-title":"Per se limits: methods of defining cut-off values for zero tolerance, deliverable 1.4.2 in the 6FP DRUID","author":"Verstraete","year":"2011"},{"key":"10.1016\/j.forsciint.2019.109914_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.forsciint.2018.10.023","article-title":"Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in whole blood of drivers involved in road accidents","volume":"294","author":"Pelletti","year":"2019","journal-title":"Forensic Sci. Int."},{"issue":"2","key":"10.1016\/j.forsciint.2019.109914_bib0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jat\/bkx082","article-title":"Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities-2017 update","volume":"42","author":"Logan","year":"2018","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.forsciint.2019.109914_bib0065","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/cc11441","article-title":"Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics","volume":"16","author":"Schulz","year":"2012","journal-title":"Crit. Care"},{"issue":"1\u201302","key":"10.1016\/j.forsciint.2019.109914_bib0070","first-page":"e1","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.forsciint.2019.109914_bib0075","series-title":"Drug Use, Impaired Driving and Traffic Accidents","author":"Verstraete","year":"2014"},{"issue":"1","key":"10.1016\/j.forsciint.2019.109914_bib0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4088\/JCP.v64n0106","article-title":"Antidepressants and driver impairment: empirical evidence from a standard on-the-road test","volume":"64","author":"Ramaekers","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.forsciint.2019.109914_bib0085","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.aap.2012.06.017","article-title":"Risk of road accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies","volume":"60","author":"Elvik","year":"2013","journal-title":"Accid. Anal. Prev."},{"key":"10.1016\/j.forsciint.2019.109914_bib0090","series-title":"Relative accident risk of patients using psychotropic medicines in the Netherlands: A pharmacoepidemiological study. Deliverable 2.3.1 in the 6FP DRUID","author":"Ravera","year":"2010"},{"issue":"6","key":"10.1016\/j.forsciint.2019.109914_bib0095","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.aap.2011.05.002","article-title":"Drugs related to motor vehicle crashes in northern European countries: a study of fatally injured drivers","volume":"43","author":"Morland","year":"2011","journal-title":"Accid. Anal. Prev."},{"key":"10.1016\/j.forsciint.2019.109914_bib0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.aap.2018.08.026","article-title":"Driving under the influence of prescription opioids: self-reported prevalence and association with collision risk in a large Canadian jurisdiction","volume":"121","author":"Wickens","year":"2018","journal-title":"Accid. Anal. Prev."},{"key":"10.1016\/j.forsciint.2019.109914_bib0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.comppsych.2016.06.008","article-title":"Socio-demographic and clinical characteristics of benzodiazepine long-term users: results from a tertiary care center","volume":"69","author":"Cosci","year":"2016","journal-title":"Compr. Psychiatry"},{"issue":"6","key":"10.1016\/j.forsciint.2019.109914_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199302","article-title":"Prevalence of drug use among drivers based on mandatory, random tests in a roadside survey","volume":"13","author":"Alcaniz","year":"2018","journal-title":"PLoS One"},{"issue":"1\u20133","key":"10.1016\/j.forsciint.2019.109914_bib0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.forsciint.2011.10.031","article-title":"Cannabis findings in drivers suspected of driving under the influence of drugs in Finland from 2006 to 2008","volume":"217","author":"Blencowe","year":"2012","journal-title":"Forensic Sci. Int."},{"issue":"8","key":"10.1016\/j.forsciint.2019.109914_bib0120","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1080\/15389588.2018.1500018","article-title":"Driving under the influence of drugs: prevalence in road traffic accidents in Italy and considerations on per se limits legislation","volume":"19","author":"Favretto","year":"2018","journal-title":"Traffic Inj. Prev."},{"key":"10.1016\/j.forsciint.2019.109914_bib0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.forsciint.2017.09.010","article-title":"Toxicological findings in suspected drug-impaired drivers in Norway\u2014trends during 1990\u20132015","volume":"280","author":"Valen","year":"2017","journal-title":"Forensic Sci. Int."},{"issue":"3","key":"10.1016\/j.forsciint.2019.109914_bib0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/15389588.2016.1201205","article-title":"Impairment due to alcohol, tetrahydrocannabinol, and benzodiazepines in impaired drivers compared to experimental studies","volume":"18","author":"Hoiseth","year":"2017","journal-title":"Traffic Inj. Prev."},{"key":"10.1016\/j.forsciint.2019.109914_bib0135","series-title":"Driving under the influence of drugs: report from the Expert Panel on Drug Driving","author":"Wolff","year":"2013"},{"issue":"1\u20133","key":"10.1016\/j.forsciint.2019.109914_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2011.11.004","article-title":"Impairment based legislative limits for driving under the influence of non-alcohol drugs in Norway","volume":"219","author":"Vindenes","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2019.109914_bib0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40621-019-0209-8","article-title":"Trends in benzodiazepine anxiolytics and z-hypnotics use among French drivers involved in road traffic crashes from 2005 to 2015: a responsibility case-control study","volume":"6","author":"Orriols","year":"2019","journal-title":"Inj. Epidemiol."},{"issue":"4","key":"10.1016\/j.forsciint.2019.109914_bib0150","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s11096-012-9658-7","article-title":"Medicines and driving: evaluation of training and software support for patient counselling by pharmacists","volume":"34","author":"Legrand","year":"2012","journal-title":"Int. J. Clin. Pharm."},{"issue":"1","key":"10.1016\/j.forsciint.2019.109914_bib0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF01061430","article-title":"Pharmacokinetics and bioavailability of intravenous and oral chlordesmethyldiazepam in humans","volume":"34","author":"Bareggi","year":"1988","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073819303263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073819303263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:58:54Z","timestamp":1759946334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073819303263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":31,"alternative-id":["S0379073819303263"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2019.109914","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of therapeutic drugs in blood of drivers involved in traffic crashes in the area of Bologna, Italy","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2019.109914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109914"}}